Lynparza on cusp of approval for advanced ovarian cancerBreast cancer drug Lynparza (olaparib) is poised for EU approval for the first-line treatment of a certain type Share XLynparza on cusp of approval for advanced ovarian cancerhttps://pharmaphorum.com/news/lynparza-on-cusp-of-approval-for-advanced-ovarian-cancer/